Personalised follow-up pathways: history, benefits and how they can be delivered – Macmillan Cancer Support Igloo session
Date and time: Mon 04-Nov-2019, 10:30 am-10:40 am
Room: Igloo - Hall 4
Programme stream(s): Living with and beyond cancer
Programme session type(s): Igloo
Personalised follow-up is a key commitment in the English NHS Long Term Plan, and Scottish and Welsh cancer plans. After more than a decade of research and testing, the benefits and challenges of personalised follow-up are better understood than ever. Macmillan Cancer Support has been at the forefront of this activity, implementing and evaluating personalised follow-up pathways at sites across England and Northern Ireland in collaboration with local trusts and commissioners. We’ve found that successful implementation requires a broad consideration of clinical and personal factors, reliable remote monitoring with fast-tracked routes back into the system, and a shared understanding between primary care, specialists and patients.
Through personalised follow-up, patients are generally better able to self-manage the practical, physical and emotional impacts of their cancer. It also releases vital appointment times, reducing waiting lists for patients for whom those appointments are most valuable.
In this session, Professor Jane Maher of Macmillan will talk through the themes of the recent ASCO paper she co-authored on personalised follow-up. Jane will outline the rationale, history and benefits of personalised pathways, as well as provide evidenced recommendations on how to take the approach forward.